Groundbreaking Clinical Trial to Assess Use of Newborn Stem Cells in the … – PR Newswire (press release)
|
Groundbreaking Clinical Trial to Assess Use of Newborn Stem Cells in the …
PR Newswire (press release) SAN BRUNO, Calif., July 13, 2015 /PRNewswire/ — Cord Blood Registry® (CBR®) announces the launch of an FDA-regulated clinical trial to investigate autologous stem cell therapy in children diagnosed as having had a prenatal or perinatal pediatric stroke. |
